These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 35325682)

  • 21. Effect of traditional medicine brahmi vati and bacoside A-rich fraction of Bacopa monnieri on acute pentylenetetrzole-induced seizures, amphetamine-induced model of schizophrenia, and scopolamine-induced memory loss in laboratory animals.
    Mishra A; Mishra AK; Jha S
    Epilepsy Behav; 2018 Mar; 80():144-151. PubMed ID: 29414544
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of the Efficacy of
    Fuladi S; Emami SA; Mohammadpour AH; Karimani A; Manteghi AA; Sahebkar A
    Curr Rev Clin Exp Pharmacol; 2021; 16(2):191-196. PubMed ID: 32282308
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of a multispecies probiotic as adjunctive therapy in generalized anxiety disorder: a double blind, randomized, placebo-controlled trial.
    Eskandarzadeh S; Effatpanah M; Khosravi-Darani K; Askari R; Hosseini AF; Reisian M; Jazayeri S
    Nutr Neurosci; 2021 Feb; 24(2):102-108. PubMed ID: 31516094
    [No Abstract]   [Full Text] [Related]  

  • 24. Efficacy of
    Maragalawaththa MGSK; Goyal M
    Ayu; 2019; 40(2):97-103. PubMed ID: 32398909
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical Efficacy of the Chinese Herbal Medicine Shumian Capsule for Insomnia: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Chen S; Xu Z; Li Y; Wang T; Yue Y; Hou Z; You L; Lu N; Yin Y; Liu X; Tan L; Ji H; Shi Y; Xin X; Jiang W; Yuan Y
    Neuropsychiatr Dis Treat; 2022; 18():669-679. PubMed ID: 35378821
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Double-blind, randomized study of extended release quetiapine fumarate (quetiapine XR) monotherapy in older patients with generalized anxiety disorder.
    Mezhebovsky I; Mägi K; She F; Datto C; Eriksson H
    Int J Geriatr Psychiatry; 2013 Jun; 28(6):615-25. PubMed ID: 23070803
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety and efficacy of aviandr in patients with generalized anxiety disorder: A multicenter, randomized, double-blind, placebo-controlled, dose-finding, pilot study.
    Ivashchenko AA; Morozova MA; Vostokova NV; Beniashvily AG; Bukhanovskaya OA; Burminskiy DS; Egorova AN; Gluskina LY; Gorchakov DS; Karapetian RN; Kasimova LN; Kravchenko DV; Lepilkina TA; Merkulova EA; Mitkin OD; Penchul NA; Potanin SS; Rupchev GE; Ivachtchenko AV
    J Psychiatr Res; 2021 Nov; 143():436-444. PubMed ID: 34656876
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of psychic factors in pathogenesis of essential hypertension and its management by Shirodhara and Sarpagandha Vati.
    Kundu C; Shukla VD; Santwani MA; Bhatt NN
    Ayu; 2010 Oct; 31(4):436-41. PubMed ID: 22048535
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Short-term open-label chamomile (Matricaria chamomilla L.) therapy of moderate to severe generalized anxiety disorder.
    Keefe JR; Mao JJ; Soeller I; Li QS; Amsterdam JD
    Phytomedicine; 2016 Dec; 23(14):1699-1705. PubMed ID: 27912871
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How well do randomized controlled trial data generalize to 'real-world' clinical practice settings? A comparison of two generalized anxiety disorder studies.
    Kasper S; Brasser M; Schweizer E; Lyndon G; Prieto R
    Eur Neuropsychopharmacol; 2014 Jan; 24(1):125-32. PubMed ID: 24290532
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and Efficacy of the Ayurvedic Formulation Guduchi Ghana Vati as a Preventive Remedy in COVID-19.
    Sharma S; Godatwar P; Pareek M; Meena H; Sharma A; Tamoli S
    Cureus; 2024 Apr; 16(4):e58807. PubMed ID: 38784353
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of hydroxyzine in the treatment of generalized anxiety disorder: a 3-month double-blind study.
    Llorca PM; Spadone C; Sol O; Danniau A; Bougerol T; Corruble E; Faruch M; Macher JP; Sermet E; Servant D
    J Clin Psychiatry; 2002 Nov; 63(11):1020-7. PubMed ID: 12444816
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comorbid generalized anxiety disorder and its association with quality of life in patients with major depressive disorder.
    Zhou Y; Cao Z; Yang M; Xi X; Guo Y; Fang M; Cheng L; Du Y
    Sci Rep; 2017 Jan; 7():40511. PubMed ID: 28098176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy, safety, and tolerability of venlafaxine extended release and buspirone in outpatients with generalized anxiety disorder.
    Davidson JR; DuPont RL; Hedges D; Haskins JT
    J Clin Psychiatry; 1999 Aug; 60(8):528-35. PubMed ID: 10485635
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A double-blind, placebo-controlled study of a CCK-B receptor antagonist, CI-988, in patients with generalized anxiety disorder.
    Adams JB; Pyke RE; Costa J; Cutler NR; Schweizer E; Wilcox CS; Wisselink PG; Greiner M; Pierce MW; Pande AC
    J Clin Psychopharmacol; 1995 Dec; 15(6):428-34. PubMed ID: 8748432
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of extended-release quetiapine fumarate on long-term functioning and sleep quality in patients with Generalized Anxiety Disorder (GAD): data from a randomized-withdrawal, placebo-controlled maintenance study.
    Sheehan DV; Svedsäter H; Locklear JC; Eriksson H
    J Affect Disord; 2013 Dec; 151(3):906-13. PubMed ID: 24135509
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Agomelatine prevents relapse in generalized anxiety disorder: a 6-month randomized, double-blind, placebo-controlled discontinuation study.
    Stein DJ; Ahokas A; Albarran C; Olivier V; Allgulander C
    J Clin Psychiatry; 2012 Jul; 73(7):1002-8. PubMed ID: 22901350
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antidepressants effects of Rhodiola capsule combined with sertraline for major depressive disorder: A randomized double-blind placebo-controlled clinical trial.
    Gao L; Wu C; Liao Y; Wang J
    J Affect Disord; 2020 Mar; 265():99-103. PubMed ID: 32090788
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and Safety of Vilazodone in Patients With Generalized Anxiety Disorder: A Randomized, Double-Blind, Placebo-Controlled, Flexible-Dose Trial.
    Durgam S; Gommoll C; Forero G; Nunez R; Tang X; Mathews M; Sheehan DV
    J Clin Psychiatry; 2016 Dec; 77(12):1687-1694. PubMed ID: 27232052
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deramciclane in the treatment of generalized anxiety disorder: a placebo-controlled, double-blind, dose-finding study.
    Naukkarinen H; Raassina R; Penttinen J; Ahokas A; Jokinen R; Koponen H; Lepola U; Kanerva H; Lehtonen L; Pohjalainen T; Partanen A; Mäki-Ikola O; Rouru J;
    Eur Neuropsychopharmacol; 2005 Dec; 15(6):617-23. PubMed ID: 15949921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.